Nichols & Pratt Advisers’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,050	Closed	-$333K	–	105
2024 Q3	$333K	Hold	5,050	–	–	0.02%	90
2024 Q2	$466K	Hold	5,050	–	–	0.03%	77
2024 Q1	$483K	Hold	5,050	–	–	0.03%	81
2023 Q4	$385K	Hold	5,050	–	–	0.03%	86
2023 Q3	$350K	Hold	5,050	–	–	0.03%	89
2023 Q2	$476K	Hold	5,050	–	–	0.03%	85
2023 Q1	$418K	Hold	5,050	–	–	0.03%	85
2022 Q4	$377K	Hold	5,050	–	–	0.03%	81
2022 Q3	$417K	Hold	5,050	–	–	0.04%	78
2022 Q2	$480K	Hold	5,050	–	–	0.04%	78
2022 Q1	$594K	Hold	5,050	–	–	0.04%	80
2021 Q4	$654K	Sell	5,050 -800	-14%	-$104K	0.05%	75
2021 Q3	$657K	Hold	5,850	–	–	0.05%	76
2021 Q2	$606K	Hold	5,850	–	–	0.05%	77
2021 Q1	$489K	Hold	5,850	–	–	0.04%	79
2020 Q4	$534K	Hold	5,850	–	–	0.04%	79
2020 Q3	$467K	Hold	5,850	–	–	0.04%	76
2020 Q2	$404K	Sell	5,850 -750	-11%	-$51.8K	0.04%	80
2020 Q1	$415K	Hold	6,600	–	–	0.04%	77
2019 Q4	$513K	Hold	6,600	–	–	0.04%	80
2019 Q3	$484K	Hold	6,600	–	–	0.04%	84
2019 Q2	$406K	Hold	6,600	–	–	0.03%	89
2019 Q1	$421K	Hold	6,600	–	–	0.04%	88
2018 Q4	$337K	Hold	6,600	–	–	0.03%	89
2018 Q3	$383K	Hold	6,600	–	–	0.03%	94
2018 Q2	$320K	Hold	6,600	–	–	0.03%	97
2018 Q1	$307K	Hold	6,600	–	–	0.03%	99
2017 Q4	$248K	Hold	6,600	–	–	0.02%	103
2017 Q3	$240K	Hold	6,600	–	–	0.02%	99
2017 Q2	$260K	Hold	6,600	–	–	0.02%	97
2017 Q1	$207K	Hold	6,600	–	–	0.02%	104
2016 Q4	$206K	Hold	6,600	–	–	0.02%	104
2016 Q3	$265K	Hold	6,600	–	–	0.02%	99
2016 Q2	$219K	Buy	+6,600	New	+$219K	0.02%	112